Development of a novel MRI contrast agent for early detection of alcoholic steatohepatitis
Ended Cooperative Agreement Awarded Last action
- Award ID
- UT2AA028659
- Recipient
-
Inlighta Biosciences L.L.C. UEI KCSBM7ASMA34
- Awarding agency
-
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,303,618
Award facts
- Assistance listing
- 93.273 Alcohol Research Programs
- Completion date
- Originally
- Funding
-
- $2,319,309.00 Federal
- $984,309.00 Non-federal
- Place of performance
- Marietta, GA 30068, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$639,239 | $0 | |
| Amendment | $984,309 | $0 | |
| Amendment | $984,309 | $984,309 | |
| Original award | $989,930 | $0 |
Quick answers
Who received award UT2AA028659?
UT2AA028659 was awarded to Inlighta Biosciences L.L.C. by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 20, 2020.
How much is award UT2AA028659 worth?
$3,303,618 has been obligated on UT2AA028659: $2,319,309 in federal funding and $984,309 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award